Kinled is Founding Partner/Limited Partner in:
Vienna
Actively supporting early-stage digital health, life sciences, and wellbeing startup founders.
London/Copenhagen
Vienna
Vienna
Globally targeting neurodegenerative diseases and comprehensive aging enhancement solutions.
London
Venture capital for sustainable, mission-critical B2B software in Europe, fostering long-term growth.
Helsinki
Nordic venture capital fund that backs innovative startups and visionary founders to create enduring companies.
Zürich
Funds private innovative drug development focused on the next generation of biological drugs.
Vienna
Zürich
European deep tech venture capital investor focused on digital, tangible and health technologies.
Bratislava/Prague
Leading seed/pre-seed investment fund in consumer, software, and deep tech, aimed at bridging Eastern Europe with MENA.
Over the years, Kinled has seeded, created, invested, and partnered with a number of regulated and unregulated funds. Today we are proud to be a Founding/Limited Partner in the following 10 funds:
